VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
EDAPEdap Tms S.a.
$4.75$178M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

EDAP logoEdap Tms S.a.(EDAP)Earnings, Financials & Key Ratios

EDAP•NASDAQ
Price updated Jun 16, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutEDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.Show more
  • Revenue$71M+10.3%
  • EBITDA-$22M-21.2%
  • Net Income-$29M-54.3%
  • EPS (Diluted)-0.78-52.9%
  • Gross Margin42.54%+2.7%
  • EBITDA Margin-30.79%-9.9%
  • Operating Margin-35.63%-11.3%
  • Net Margin-41.47%-39.8%
  • ROE-97.29%-150.2%

EDAP Key Insights

Edap Tms S.a. (EDAP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 92 (top 8%)
  • ✓Strong 5Y sales CAGR of 11.2%

✗Weaknesses

  • ✗Profits declining 76.7% over 5 years
  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when EDAP posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

EDAP Price & Volume

Edap Tms S.a. (EDAP) stock price & volume — 10-year historical chart

Loading chart...

EDAP Growth Metrics

Edap Tms S.a. (EDAP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.17%
5 Years11.17%
3 Years8.68%
TTM14.72%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-39.35%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-42.59%

Return on Capital

10 Years-13.17%
5 Years-25.96%
3 Years-40.06%
Last Year-55.95%

EDAP Recent Earnings

Edap Tms S.a. (EDAP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.24-9.1%
$0.22
Rev
$18M+7.4%
$17M
Q2 2026
Mar 25, 2026
Metric
Actual
Est
EPS
$0.25-56.3%
$0.16
Rev
$22M+2.6%
$21M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.15+42.3%
$0.26
Rev
$16M-23.6%
$21M
Q3 2025
Aug 28, 2025
Metric
Actual
Est
EPS
$0.17+5.6%
$0.18
Rev
$19M+29.5%
$15M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.24vs $0.22-9.1%
$18Mvs $17M+7.4%
Q2 2026Mar 25, 2026
$0.25vs $0.16-56.3%
$22Mvs $21M+2.6%
Q4 2025Nov 6, 2025
$0.15vs $0.26+42.3%
$16Mvs $21M-23.6%
Q3 2025Aug 28, 2025
$0.17vs $0.18+5.6%
$19Mvs $15M+29.5%
Based on last 12 quarters of dataView full earnings history →

EDAP Peer Comparison

Edap Tms S.a. (EDAP) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
ISRG logoISRGIntuitive Surgical, Inc.Direct Competitor144.48B406.7851.6920.51%28.15%16.89%0.02
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
IRTC logoIRTCiRhythm Technologies, Inc.Direct Competitor3.44B104.65-75.2926.24%-3.53%-20.6%4.79
GKOS logoGKOSGlaukos CorporationProduct Competitor7.65B130.68-39.8432.33%-34.34%-26.46%0.21
VIST logoVISTVista Energy, S.A.B. de C.V.Product Competitor7.15B68.5510.2250.15%25.65%30.86%1.31
PCVX logoPCVXVaxcyte, Inc.Product Competitor7.43B51.44-9.14-32.51%0.09
MDT logoMDTMedtronic plcSupply Chain101.86B79.3421.983.62%13%9.49%0.59

Compare EDAP vs Peers

Edap Tms S.a. (EDAP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AEYE

Most directly comparable listed peer for EDAP.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare EDAP against a more recognizable public peer.

Peer Set

Compare Top 5

vs AEYE, ISRG, NVCR, IRTC

EDAP Income Statement

Edap Tms S.a. (EDAP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
35.75M39.18M44.91M41.66M44.07M55.11M60.42M64.11M70.75M72M
Revenue Growth %
0.38%9.61%14.62%-7.23%5.77%25.06%9.64%6.11%10.34%14.72%
Cost of Goods Sold
20.94M22.27M23.91M23.28M25.64M30.92M36.01M37.56M40.65M40.72M
COGS % of Revenue
58.57%56.83%53.24%55.89%58.19%56.1%59.6%58.58%57.46%-
Gross Profit
14.81M▲ 0%
16.92M▲ 14.2%
21M▲ 24.2%
18.38M▼ 12.5%
18.42M▲ 0.2%
24.19M▲ 31.3%
24.41M▲ 0.9%
26.56M▲ 8.8%
30.09M▲ 13.3%
31.28M▲ 0%
Gross Margin %
41.43%43.17%46.76%44.11%41.81%43.9%40.4%41.42%42.54%43.45%
Gross Profit Growth %
-9.77%14.24%24.15%-12.49%0.24%31.32%0.9%8.79%13.32%-
Operating Expenses
16.84M18.23M18.8M18.11M20.04M28.45M44.22M47.09M55.3M56.22M
OpEx % of Revenue
47.1%46.53%41.86%43.47%45.47%51.63%73.19%73.45%78.17%-
Selling, General & Admin
12.95M14.14M15.07M13.61M16.63M23.53M37.26M39.36M45.03M22.18M
SG&A % of Revenue
36.24%36.1%33.56%32.68%37.74%42.7%61.67%61.4%63.66%-
Research & Development
3.88M4.09M3.73M4.5M4.76M4.92M6.96M7.73M8.55M9.36M
R&D % of Revenue
10.86%10.43%8.3%10.79%10.8%8.93%11.52%12.05%12.09%-
Other Operating Expenses
00-1K0-1.35M01K01.72M2M
Operating Income
-2.03M▲ 0%
-1.31M▲ 35.1%
2.2M▲ 267.4%
269K▼ 87.8%
-1.61M▼ 699.3%
-4.26M▼ 164.1%
-19.81M▼ 365.4%
-20.53M▼ 3.6%
-25.21M▼ 22.8%
-24.93M▲ 0%
Operating Margin %
-5.67%-3.36%4.9%0.65%-3.66%-7.72%-32.79%-32.03%-35.63%-34.63%
Operating Income Growth %
-617.09%35.13%267.38%-87.78%-699.26%-164.08%-365.42%-3.64%-22.77%-
EBITDA
-549.45K209.29K4.08M2.37M308K-2.65M-17.9M-17.97M-21.78M-23.39M
EBITDA Margin %
-1.54%0.53%9.08%5.7%0.7%-4.81%-29.62%-28.03%-30.79%-32.49%
EBITDA Growth %
-137.45%138.09%1849.47%-41.81%-87.03%-959.9%-575.85%-0.39%-21.22%-20.12%
D&A (Non-Cash Add-back)
1.48M1.52M1.88M2.1M1.92M1.61M1.91M2.56M3.43M1.54M
EBIT
-249K131K2.36M268K-1.61M-1.93M-20.3M-18.49M-25.21M-24.93M
Net Interest Income
599K797K-145K-98K-42K236K1.08M560K-538.66K-4.84M
Interest Income
18K19K20K10K10K404K1.31M796K252.78K0
Interest Expense
44K111K165K108K52K168K232K236K791.44K4.84M
Other Income/Expense
1.73M1.33M-10K-1.46M2.5M2.16M-720K1.8M-4.06M-4.67M
Pretax Income
-294K▲ 0%
20K▲ 106.8%
2.19M▲ 10855.0%
-1.19M▼ 154.2%
893K▲ 175.2%
-2.1M▼ 334.7%
-20.53M▼ 879.6%
-18.73M▲ 8.8%
-29.27M▼ 56.3%
-29.6M▲ 0%
Pretax Margin %
-0.82%0.05%4.88%-2.85%2.03%-3.8%-33.98%-29.21%-41.37%-41.11%
Income Tax
388K358K679K516K193K837K644K289K71.22K423.85K
Effective Tax Rate %
-131.97%1790%30.99%-43.43%21.61%-39.93%-3.14%-1.54%-0.24%-1.43%
Net Income
-681K▲ 0%
-338K▲ 50.4%
1.51M▲ 547.3%
-1.7M▼ 212.7%
700K▲ 141.1%
-2.93M▼ 519.0%
-21.18M▼ 622.1%
-19.02M▲ 10.2%
-29.34M▼ 54.3%
-30.02M▲ 0%
Net Margin %
-1.91%-0.86%3.37%-4.09%1.59%-5.32%-35.05%-29.66%-41.47%-41.7%
Net Income Growth %
-117.73%50.37%547.34%-212.7%141.08%-519%-622.06%10.2%-54.26%-39.35%
Net Income (Continuing)
-681K-338K1.51M-1.7M700K-2.93M-21.18M-19.02M-29.34M-30.02M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.02▲ 0%
-0.01▲ 50.2%
0.05▲ 535.0%
-0.06▼ 214.9%
0.02▲ 138.3%
-0.09▼ 480.8%
-0.57▼ 568.2%
-0.51▲ 10.5%
-0.78▼ 52.9%
-0.80▲ 0%
EPS Growth %
-118.08%50.21%535.04%-214.93%138.29%-480.8%-568.23%10.53%-52.94%-42.59%
EPS (Basic)
-0.02-0.010.05-0.060.02-0.09-0.57-0.51-0.78-
Diluted Shares Outstanding
28.96M29M29.62M29.15M32.42M34.39M37M37.29M37.44M37.48M
Basic Shares Outstanding
28.96M29M29.02M29.15M32.13M34.39M37M37.29M37.44M37.48M
Dividend Payout Ratio
----------

EDAP Balance Sheet

Edap Tms S.a. (EDAP) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
39.74M40.38M42.1M45.39M67.38M90.52M78.48M69.88M57.16M50.36M
Cash & Short-Term Investments
20M19.46M20.89M24.7M47.18M63.14M43.47M29.84M17.41M15.01M
Cash Only
20M19.46M20.89M24.7M47.18M63.14M43.47M29.84M17.41M15.01M
Short-Term Investments
0000000000
Accounts Receivable
11.57M12.24M11.33M10.64M12.12M14.94M16.96M20.29M22.58M20.33M
Days Sales Outstanding
118.11114.0592.0693.22100.3998.96102.46115.51116.52101.97
Inventory
6.74M7.21M8.18M7.99M7.5M11.78M15.11M18.5M10.92M13.33M
Days Inventory Outstanding
117.48118.22124.85125.24106.74139.08153.17179.7498.04120.08
Other Current Assets
1.06M1.43M1.26M1.7M-1K02.28M-3K5.15M1.69M
Total Non-Current Assets
7.33M8.36M10.97M9.8M9.84M10.61M13.07M16.19M21.83M21.7M
Property, Plant & Equipment
3.68M4.21M6.72M5.6M5.17M5.99M8.19M10.34M11.49M13.01M
Fixed Asset Turnover
9.71x9.31x6.69x7.44x8.52x9.21x7.37x6.20x6.15x6.44x
Goodwill
2.41M2.41M2.41M2.41M2.41M2.41M2.41M2.41M2.83M2.77M
Intangible Assets
527K847K770K761K728K724K1.08M1.09M1.8M0
Long-Term Investments
77K26K2K00000464.7K464.7K
Other Non-Current Assets
462K546K640K1.03M634K656K1.38M1.52M5.24M5.92M
Total Assets
46.9M▲ 0%
48.74M▲ 3.9%
53.07M▲ 8.9%
55.19M▲ 4.0%
77.23M▲ 39.9%
101.12M▲ 30.9%
91.55M▼ 9.5%
86.06M▼ 6.0%
79M▼ 8.2%
72.06M▲ 0%
Asset Turnover
0.76x0.80x0.85x0.75x0.57x0.54x0.66x0.74x0.90x1.03x
Asset Growth %
0.66%3.93%8.88%4%39.92%30.94%-9.47%-5.99%-8.21%-51.17%
Total Current Liabilities
16.13M16.81M17.49M21.5M17.95M21.71M27.6M37.81M37.14M37.51M
Accounts Payable
6.31M6.3M6.03M5.71M5.51M6.64M11.24M12.56M17.6M21.85M
Days Payables Outstanding
110103.2292.1289.4878.4478.39113.88122.03158.06167.72
Short-Term Debt
3.1M4.17M3.98M7.17M2.74M3.45M4.02M8.65M8.11M0
Deferred Revenue (Current)
2.29M1.93M1.89M03.41M4.05M83.75K6.64M6.04M19.76M
Other Current Liabilities
3.65M2.72M552K3.65M2.02M2.35M5.07M3.23M4.15M7.84M
Current Ratio
2.46x2.40x2.41x2.11x3.75x4.17x2.84x1.85x1.54x1.34x
Quick Ratio
2.05x1.97x1.94x1.74x3.34x3.63x2.30x1.36x1.25x0.99x
Cash Conversion Cycle
125.59129.05124.8128.98128.69159.65141.75173.2156.554.33
Total Non-Current Liabilities
5.61M6.96M8.22M7.44M9.22M7.79M7.03M7.36M22.44M24.45M
Long-Term Debt
834K1.34M957K1.14M4.93M3.59M2M2.16M15.9M2.35M
Capital Lease Obligations
528K852K2.38M1.65M1.32M1.22M1.31M1.94M2.43M5.58M
Deferred Tax Liabilities
2.29M3.77M3.52M0000000
Other Non-Current Liabilities
1.95M1M47K4.64M2.53M2.71M3.07M2.9M3.14M22.11M
Total Liabilities
21.74M23.78M25.71M28.95M27.17M29.49M34.63M45.17M59.58M61.96M
Total Debt
4.72M6.75M8.66M11.11M10.01M9.38M8.42M13.92M27.68M2.35M
Net Debt
-15.29M-12.72M-12.22M-13.58M-37.18M-53.75M-35.05M-15.92M10.28M-12.67M
Debt / Equity
0.19x0.27x0.32x0.42x0.20x0.13x0.15x0.34x1.43x0.23x
Debt / EBITDA
-32.24x2.12x4.68x32.48x-----0.10x
Net Debt / EBITDA
--60.76x-3.00x-5.72x-120.71x----0.54x
Interest Coverage
-5.66x1.18x14.28x2.48x-30.98x-11.48x-87.50x-78.36x-31.85x-5.15x
Total Equity
25.16M▲ 0%
24.96M▼ 0.8%
27.36M▲ 9.6%
26.25M▼ 4.1%
50.05M▲ 90.7%
71.63M▲ 43.1%
56.92M▼ 20.5%
40.9M▼ 28.2%
19.41M▼ 52.5%
10.1M▲ 0%
Equity Growth %
2.89%-0.77%9.59%-4.06%90.7%43.1%-20.53%-28.16%-52.53%-210.12%
Book Value per Share
0.870.860.920.901.542.081.541.100.520.27
Total Shareholders' Equity
25.16M24.96M27.36M26.25M50.05M71.63M56.92M40.9M19.41M10.1M
Common Stock
3.82M3.82M3.83M3.83M4.39M4.78M4.85M4.89M6.07M0
Retained Earnings
-39.61M-39.95M-38.44M-40.14M-39.44M-42.37M-63.55M-82.57M-128.62M0
Treasury Stock
-1.14M-1.14M-928K-928K-928K-897K-800K-800K-1.02M0
Accumulated OCI
-3.6M-3.75M-3.44M-3.06M-3.59M-3.83M-4.49M-4.89M-8.34M0
Minority Interest
0000000000

EDAP Cash Flow Statement

Edap Tms S.a. (EDAP) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-3.06M175K3.8M2.25M4.45M-3.02M-14.68M-13.58M-16.41M-14.08M
Operating CF Margin %
-8.56%0.45%8.46%5.41%10.09%-5.49%-24.29%-21.19%-23.19%-
Operating CF Growth %
-373.37%105.72%2071.43%-40.69%97.23%-168.03%-385.38%7.45%-20.8%85.37%
Net Income
-681K-338K1.51M-1.94M700K-2.93M-21.18M-19.02M-29.25M-30.02M
Depreciation & Amortization
1.57M1.61M1.88M2.52M1.92M1.6M1.91M2.56M3.41M0
Stock-Based Compensation
382K289K260K01.9M2.1M6.87M3.28M2.56M0
Deferred Taxes
-153K-153K-106K51.3K-563K48K42K-97K-231K0
Other Non-Cash Items
-2.49M39K247K1.75M-33K469K583K1.65M4.17M-20.04M
Working Capital Changes
-1.69M-1.27M8K-124.26K521K-4.32M-2.9M-1.96M2.93M4.38M
Change in Receivables
-1.64M-1.01M908K1.3M-103K-1.94M-4.91M-139K-567K0
Change in Inventory
669K-704K-1.04M-631.54K166K-4.48M-4.21M-4.04M6.85M0
Change in Payables
426K-70K-249K-481.07K01.12M0000
Cash from Investing
-2.03M-1.57M-1.53M-2.29M-1.64M-2.38M-4.34M-4.12M-5.71M-5.18M
Capital Expenditures
-2.07M-1.87M-396K-722.74K-393K-2.18M-1.18M-1.31M-1.21M-4.54M
CapEx % of Revenue
5.8%4.77%0.88%1.73%0.89%3.96%1.95%2.05%1.71%6.3%
Acquisitions
79.84K370.49K00000000
Investments
----------
Other Investing
40K300K-1.12M-1.57M-1.26M-195K-3.17M-2.81M-4.5M-644.05K
Cash from Financing
2.87M1.18M-664K3.65M20.27M21.74M-911K4.63M8.61M8.51M
Debt Issued (Net)
2.21M1.18M-974K3.58M-1.47M-867K-1.17M4.52M8.61M0
Equity Issued (Net)
548K0068.4K21.29M21.96M0000
Dividends Paid
0000000000
Share Repurchases
0000000000
Other Financing
115K1K310K0443K648K261K115K08.51M
Net Change in Cash
-1.99M▲ 0%
-540K▲ 72.8%
1.42M▲ 363.3%
6.77M▲ 376.2%
22.49M▲ 232.0%
15.95M▼ 29.1%
-19.66M▼ 223.3%
-13.63M▲ 30.7%
-10.54M▲ 22.7%
15.01M▲ 0%
Free Cash Flow
-5.13M▲ 0%
-1.69M▲ 67.0%
2.35M▲ 238.7%
1.65M▼ 29.8%
2.8M▲ 69.8%
-5.21M▼ 286.0%
-18.97M▼ 264.4%
-17.68M▲ 6.8%
-22.17M▼ 25.3%
-19.27M▲ 0%
FCF Margin %
-14.35%-4.32%5.23%3.96%6.35%-9.45%-31.4%-27.58%-31.34%-26.77%
FCF Growth %
-2378.74%66.98%238.67%-29.83%69.8%-286.03%-264.39%6.79%-25.35%0.77%
FCF per Share
-0.18-0.060.080.060.09-0.15-0.51-0.47-0.59-0.51
FCF Conversion (FCF/Net Income)
4.49x-0.52x2.51x-1.32x6.35x1.03x0.69x0.71x0.56x0.64x
Interest Paid
0000000000
Taxes Paid
0000000000

EDAP Key Ratios

Edap Tms S.a. (EDAP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-2.75%-1.35%5.78%-6.36%1.83%-4.82%-32.95%-38.88%-97.29%-148.9%
Return on Invested Capital (ROIC)
-20.14%-8.92%12.06%1.45%-9.47%-20.76%-74.76%-65.74%-69.17%-110.09%
Gross Margin
41.43%43.17%46.76%44.11%41.81%43.9%40.4%41.42%42.54%43.45%
Net Margin
-1.91%-0.86%3.37%-4.09%1.59%-5.32%-35.05%-29.66%-41.47%-41.7%
Debt / Equity
0.19x0.27x0.32x0.42x0.20x0.13x0.15x0.34x1.43x0.23x
Interest Coverage
-5.66x1.18x14.28x2.48x-30.98x-11.48x-87.50x-78.36x-31.85x-5.15x
FCF Conversion
4.49x-0.52x2.51x-1.32x6.35x1.03x0.69x0.71x0.56x0.64x
Revenue Growth
0.38%9.61%14.62%-7.23%5.77%25.06%9.64%6.11%10.34%14.72%
Related:EDAP Dividend History·EDAP Revenue History·EDAP Price History·EDAP P/E History·EDAP Financial Ratios·EDAP Institutional Holders

EDAP SEC Filings & Documents

Edap Tms S.a. (EDAP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Apr 2, 2026·SEC

Material company update

Mar 25, 2026·SEC

10-K Annual Reports

1
FY 2026

Mar 25, 2026·SEC

10-Q Quarterly Reports

1
FY 2026

May 7, 2026·SEC

EDAP Frequently Asked Questions

Edap Tms S.a. (EDAP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Edap Tms S.a. (EDAP) reported $72.0M in revenue for fiscal year 2025. This represents a 120% increase from $32.7M in 1997.

Edap Tms S.a. (EDAP) grew revenue by 10.3% over the past year. This is steady growth.

Edap Tms S.a. (EDAP) reported a net loss of $30.0M for fiscal year 2025.

Dividend & Returns

Edap Tms S.a. (EDAP) has a return on equity (ROE) of -97.3%. Negative ROE indicates the company is unprofitable.

Edap Tms S.a. (EDAP) had negative free cash flow of $19.3M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in EDAP back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →

How much would $100/month in EDAP be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →